Volume 10, Number 11—November 2004
Research
Enhanced Identification of Postoperative Infections among Inpatients
Table 2
SSI rates after CABG procedures, cesarean delivery, and breast proceduresa,b
| Procedure/phase | SSI rates detected by |
|
|---|---|---|
| % routine surveillance (SSI/ procedures) [95% CI] | Any method %c (SSI/procedures) [95% CI] | |
| CABG | ||
| Phase 1 | 4.9 (112/2,267) [4.1%–5.9%] | 6.3 (142/2,267) [5.3%–7.3%] |
| Phase 2 | 4.6 (298/6,472) [4.1%–5.1%] | 7.7 (501/6,472) [7.1%–8.9%] |
| Combined | 4.7 (410/8,739) | 7.4 (643/8,739) |
| Cesarean delivery | ||
| Phase 1 | 1.6 (43/2,659) [1.2%–2.2%] | 4.1 (110/2,659) [3.4%–5.0%] |
| Phase 2 | 1.6 (49/3,065)d [1.2%–2.1%] | 5.5 (263/4,740) [4.8%–6.3%] |
| Combined | 1.6 (92/5,724) | 5.0 (373/7,399) |
| Breast procedures | ||
| Phase 1 | 0.7 (10/1,477) [0.3%–1.2%] | 0.9 (14/1,477) [0.5%–1.6%] |
| Phase 2 | 0.4 (7/1,765)d [0.2%–0.8%] | 2.3 (110/4,698) [2.1%–2.8%] |
| Combined | 0.5 (17/3,242) | 2.0 (124/6,175) |
aBased on routine surveillance and routine surveillance plus screening for antimicrobial drug exposure, discharge diagnosis codes, or both.
bSSI, surgical site infection; CABG, coronary artery bypass graft; CI, confidence interval.
cRoutine, antimicrobial exposure, diagnosis codes.
dThe total number of procedures is noted for the hospitals that had performed routine surveillance.


